PHGUF
Price
$0.90
Change
+$0.11 (+13.92%)
Updated
Mar 13 closing price
Capitalization
534.38M
XFOR
Price
$0.21
Change
-$0.00 (-0.00%)
Updated
Apr 4 closing price
Capitalization
36.49M
33 days until earnings call
Ad is loading...

PHGUF vs XFOR

Header iconPHGUF vs XFOR Comparison
Open Charts PHGUF vs XFORBanner chart's image
Pharming Group
Price$0.90
Change+$0.11 (+13.92%)
Volume$171K
Capitalization534.38M
X4 Pharmaceuticals
Price$0.21
Change-$0.00 (-0.00%)
Volume$2.4M
Capitalization36.49M
PHGUF vs XFOR Comparison Chart
Loading...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHGUF vs. XFOR commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHGUF is a Hold and XFOR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (PHGUF: $0.90 vs. XFOR: $0.21)
Brand notoriety: PHGUF and XFOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHGUF: 107% vs. XFOR: 42%
Market capitalization -- PHGUF: $534.38M vs. XFOR: $36.49M
PHGUF [@Biotechnology] is valued at $534.38M. XFOR’s [@Biotechnology] market capitalization is $36.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHGUF’s FA Score shows that 1 FA rating(s) are green whileXFOR’s FA Score has 0 green FA rating(s).

  • PHGUF’s FA Score: 1 green, 4 red.
  • XFOR’s FA Score: 0 green, 5 red.
According to our system of comparison, PHGUF is a better buy in the long-term than XFOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

XFOR’s TA Score shows that 4 TA indicator(s) are bullish.

  • XFOR’s TA Score: 4 bullish, 3 bearish.

Price Growth

PHGUF (@Biotechnology) experienced а 0.00% price change this week, while XFOR (@Biotechnology) price change was -22.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

XFOR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHGUF($534M) has a higher market cap than XFOR($36.5M). PHGUF YTD gains are higher at: -8.304 vs. XFOR (-71.374). PHGUF has higher annual earnings (EBITDA): 7.56M vs. XFOR (-7.74M). PHGUF has more cash in the bank: 172M vs. XFOR (135M). XFOR has less debt than PHGUF: XFOR (78.2M) vs PHGUF (127M). PHGUF has higher revenues than XFOR: PHGUF (286M) vs XFOR (1.12M).
PHGUFXFORPHGUF / XFOR
Capitalization534M36.5M1,463%
EBITDA7.56M-7.74M-98%
Gain YTD-8.304-71.37412%
P/E RatioN/A3.10-
Revenue286M1.12M25,467%
Total Cash172M135M127%
Total Debt127M78.2M162%
FUNDAMENTALS RATINGS
PHGUF vs XFOR: Fundamental Ratings
PHGUF
XFOR
OUTLOOK RATING
1..100
338
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9296
PRICE GROWTH RATING
1..100
5697
P/E GROWTH RATING
1..100
1085
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XFOR's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for PHGUF (79) in the null industry. This means that XFOR’s stock grew somewhat faster than PHGUF’s over the last 12 months.

XFOR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PHGUF (100) in the null industry. This means that XFOR’s stock grew similarly to PHGUF’s over the last 12 months.

PHGUF's SMR Rating (92) in the null industry is in the same range as XFOR (96) in the Biotechnology industry. This means that PHGUF’s stock grew similarly to XFOR’s over the last 12 months.

PHGUF's Price Growth Rating (56) in the null industry is somewhat better than the same rating for XFOR (97) in the Biotechnology industry. This means that PHGUF’s stock grew somewhat faster than XFOR’s over the last 12 months.

PHGUF's P/E Growth Rating (10) in the null industry is significantly better than the same rating for XFOR (85) in the Biotechnology industry. This means that PHGUF’s stock grew significantly faster than XFOR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
XFOR
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUOTY5.350.29
+5.73%
AUO CORPORATION
AAIGF7.54-0.04
-0.58%
AIA Group, Ltd.
RNLSY10.04-0.21
-2.05%
Renault SA
KBLB0.09N/A
-2.18%
Kraig Biocraft Laboratories, Inc.
BRDCY19.11-0.79
-3.97%
Bridgestone Corp.

PHGUF and

Correlation & Price change

A.I.dvisor tells us that PHGUF and DRUG have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHGUF and DRUG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHGUF
1D Price
Change %
PHGUF100%
N/A
DRUG - PHGUF
28%
Poorly correlated
-6.20%
CGTX - PHGUF
25%
Poorly correlated
-6.51%
IMMP - PHGUF
23%
Poorly correlated
-3.59%
XFOR - PHGUF
23%
Poorly correlated
-7.89%
TVGN - PHGUF
22%
Poorly correlated
-6.54%
More

XFOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with IMMP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XFOR
1D Price
Change %
XFOR100%
-7.89%
IMMP - XFOR
37%
Loosely correlated
-3.59%
XCUR - XFOR
34%
Loosely correlated
+7.56%
SPHDF - XFOR
34%
Loosely correlated
N/A
LRMR - XFOR
30%
Poorly correlated
-10.00%
CRDF - XFOR
30%
Poorly correlated
-4.65%
More